Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 113


Expression of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ in the lung tissue of obese mice and the effect of rosiglitazone on proinflammatory cytokine expressions in the lung tissue.

Ryu SL, Shim JW, Kim DS, Jung HL, Park MS, Park SH, Lee J, Lee WY, Shim JY.

Korean J Pediatr. 2013 Apr;56(4):151-8. doi: 10.3345/kjp.2013.56.4.151. Epub 2013 Apr 22.


Effects of diet-induced mild obesity on airway hyperreactivity and lung inflammation in mice.

Jung SH, Kwon JM, Shim JW, Kim DS, Jung HL, Park MS, Park SH, Lee J, Lee WY, Shim JY.

Yonsei Med J. 2013 Nov;54(6):1430-7. doi: 10.3349/ymj.2013.54.6.1430.


Peroxisome proliferator-activated receptor-gamma expression in the lung tissue of obese rats.

Hwang SJ, Kim JH, Shim JW, Kim DS, Jung HL, Park MS, Lee WY, Kim SY, Shim JY.

Yonsei Med J. 2011 May;52(3):495-501. doi: 10.3349/ymj.2011.52.3.495. Erratum in: Yonsei Med J. 2011 Jul;52(4):699. Kim, Duk Soo [corrected to Kim, Deok Soo].


[Effects of rosiglitazone on peroxisome proliferator activated receptor-γ pathway in patients with chronic obstructive pulmonary disease].

Zeng XL, Liu XJ, Bao HR, Zhang Y, Tan EL, Liao JM.

Zhonghua Jie He He Hu Xi Za Zhi. 2011 Oct;34(10):743-8. Chinese.


Effect of peroxisome proliferator-activated receptor-gamma on airway smooth muscle thickening in a murine model of chronic asthma.

Rhee CK, Lee SY, Kang JY, Kim SJ, Kwon SS, Kim YK, Park SH.

Int Arch Allergy Immunol. 2009;148(4):289-96. doi: 10.1159/000170382. Epub 2008 Nov 11.


Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.

Liu DS, Liu WJ, Chen L, Ou XM, Wang T, Feng YL, Zhang SF, Xu D, Chen YJ, Wen FQ.

Toxicology. 2009 Jun 16;260(1-3):112-9. doi: 10.1016/j.tox.2009.03.016. Epub 2009 Apr 5.


Peroxisome proliferator activated receptor-gamma, leptin and tumor necrosis factor-alpha mRNA expression during very low calorie diet in subcutaneous adipose tissue in obese women.

Bastard JP, Hainque B, Dusserre E, Bruckert E, Robin D, Vallier P, Perche S, Robin P, Turpin G, Jardel C, Laville M, Forest C, Vidal H.

Diabetes Metab Res Rev. 1999 Mar-Apr;15(2):92-8.


Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines.

Guo C, Ricchiuti V, Lian BQ, Yao TM, Coutinho P, Romero JR, Li J, Williams GH, Adler GK.

Circulation. 2008 Apr 29;117(17):2253-61. doi: 10.1161/CIRCULATIONAHA.107.748640. Epub 2008 Apr 21.


Regulation of peroxisome proliferator-activated receptor-alpha expression during lung inflammation.

Becker J, Delayre-Orthez C, Frossard N, Pons F.

Pulm Pharmacol Ther. 2008;21(2):324-30. Epub 2007 Aug 21.


Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation.

Park SJ, Lee KS, Kim SR, Min KH, Choe YH, Moon H, Chae HJ, Yoo WH, Lee YC.

J Immunol. 2009 Sep 1;183(5):3259-67. doi: 10.4049/jimmunol.0900231. Epub 2009 Jul 29.


Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.

Verreth W, De Keyzer D, Pelat M, Verhamme P, Ganame J, Bielicki JK, Mertens A, Quarck R, Benhabilès N, Marguerie G, Mackness B, Mackness M, Ninio E, Herregods MC, Balligand JL, Holvoet P.

Circulation. 2004 Nov 16;110(20):3259-69. Epub 2004 Nov 8.


Glycine regulates inflammatory markers modifying the energetic balance through PPAR and UCP-2.

Almanza-Perez JC, Alarcon-Aguilar FJ, Blancas-Flores G, Campos-Sepulveda AE, Roman-Ramos R, Garcia-Macedo R, Cruz M.

Biomed Pharmacother. 2010 Oct;64(8):534-40. doi: 10.1016/j.biopha.2009.04.047. Epub 2009 Oct 17.


Suppression of allergen-induced airway inflammation and immune response by the peroxisome proliferator-activated receptor-alpha agonist fenofibrate.

Delayre-Orthez C, Becker J, Auwerx J, Frossard N, Pons F.

Eur J Pharmacol. 2008 Feb 26;581(1-2):177-84. Epub 2007 Nov 28.


Activation of peroxisome proliferator-activated receptor-gamma in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma.

Hammad H, de Heer HJ, Soullié T, Angeli V, Trottein F, Hoogsteden HC, Lambrecht BN.

Am J Pathol. 2004 Jan;164(1):263-71.


Inhibition of proliferation and transforming growth factor beta3 protein expression by peroxisome proliferators-activated receptor gamma ligands in human uterine leiomyoma cells.

Zhang CH, Wen ZQ, Li JF, Li CZ, Shi M, Yang GW, Lan SM, Zhu Y, Wang F, Zhang YJ, Wang YY, Zhang H.

Chin Med J (Engl). 2008 Jan 20;121(2):166-71.


Agonists of peroxisome proliferators-activated receptors (PPAR) alpha, beta/delta or gamma reduce transforming growth factor (TGF)-beta-induced proteoglycans' production in chondrocytes.

Poleni PE, Bianchi A, Etienne S, Koufany M, Sebillaud S, Netter P, Terlain B, Jouzeau JY.

Osteoarthritis Cartilage. 2007 May;15(5):493-505. Epub 2006 Nov 29.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk